Effects of ibopamine on the increase in plasma norepinephrine levels during exercise in congestive heart failure
- 1 April 1993
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 71 (11) , 992-994
- https://doi.org/10.1016/0002-9149(93)90920-8
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failurePublished by Elsevier ,2010
- Effects of Ibopamine on Exercise-Induced Increase in Norepinephrine in Normal MenJournal of Cardiovascular Pharmacology, 1992
- Endogenous Dopamine (DA) and DA2 Receptors: A Mechanism Limiting Excessive Sympathetic-Adrenal Discharge in Humans*Journal of Clinical Endocrinology & Metabolism, 1988
- Effects of long-term therapy with oral ibopamine on resting hemodynamics and exercise capacity in patients with heart failure: relationship to the generation of N-methyldopamine and to plasma norepinephrine levels.Circulation, 1986
- Controlled trial of enalapril in congestive cardiac failure.Heart, 1985
- Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failureThe American Journal of Cardiology, 1982